Navigation Links
Bayer Issues Additional Guidance to Physicians on Trasylol(R)
Date:10/25/2007

ardiac surgical patients undergoing either re-operation for coronary heart bypass graft (CABG) or aortic valve replacement, or combined valves or valve/CABG procedures. For information on the BART study, visit: http://www.ohri.ca/programs/clinical_epidemiology/thrombosis_group/studies/BART.as p

About Trasylol

Important Safety Considerations

Trasylol(R) administration may cause fatal anaphylactic or anaphylactoid reactions. Fatal reactions have occurred with an initial (test) dose as well as with any of the components of the dose regimen. Fatal reactions have also occurred in situations where the initial (test) dose was tolerated. The risk for anaphylactic or anaphylactoid reactions is increased among patients with prior aprotinin exposure and a history of any prior aprotinin exposure must be sought prior to Trasylol(R) administration. The risk for a fatal reaction appears to be greater upon re-exposure within 12 months of the most recent prior aprotinin exposure. Trasylol(R) should be administered only in operative settings where cardio-pulmonary bypass can be rapidly initiated. The benefit of Trasylol(R) to patients undergoing primary CABG surgery should be weighed against the risk of anaphylaxis associated with any subsequent exposure to aprotinin.

(See CONTRAINDICATIONS, WARNINGS and PRECAUTIONS in the prescribing information.)

Safety Considerations

Trasylol is contraindicated in patients with a known or suspected

aprotinin exposure during the last 12 months. Aprotinin may also be a

component of some fibrin sealant products.

-- In clinical studies, hypersensitivity and anaphylactic reactions were rare (<0.1%) in patients with no prior exposure to Trasylol.

Trasylol administration increases the risk for renal dysfunction and

may increase the need for dialysis in the perioperative p
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
2. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
3. FDA Issues Safety Alert on Avandia
4. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
5. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
8. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
9. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
10. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
11. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
(Date:5/23/2013)... , May 23, 2013 Hearing health affects a ... younger, and remain socially and professionally engaged, he should address ... overriding message that the Better Hearing Institute (BHI) ... National Men,s Health Week , which leads up to ... runs from June 10 through June 16. ...
(Date:5/23/2013)... More than half of women diagnosed with ... and still have excellent outcomes. To educate women, Agendia, ... largest sources of online consumer information about breast cancer ... provide recently diagnosed women with information sources, to help ... "We anticipate these innovative social media campaigns will ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... Inc. (OTCBB: UGNE), a leader in the ... the appointment of Thomas J. Sabatino, Jr. to its Board ... President and General Counsel for Walgreen Co., (NYSE: ... IL.  He joined Walgreens in September 2011 after having held ...
... Amsterdam Molecular Therapeutics (Euronext: AMT), a leader ... that the European Medicines Agency (EMA) has granted orphan ... of hemophilia B. Orphan designation in the European Union ... from product launch and access to the central authorization ...
Cached Medicine Technology:Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. 2Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. 3Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. 4Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy 2
(Date:5/25/2013)... According to an article in the June 2013 issue ... million Americans tan indoors each year and an unknown number ... health risks. New research suggests that UV rays may ... brains of some tanners (Go to goo.gl/hdwnz). , “There ... say that I fully support this contention from a scientific ...
(Date:5/25/2013)... 2013 Dr. Leslie Gerstman announced ... to lift skin on the neck, on the brow and ... Medical Aesthetics. , Ultherapy is a non-surgical procedure for the ... process to lift the skin over time. The use of ... see and then treat the deepest support layers of the ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 A disorder ... type of peripheral neuropathy. According to neuropathy expert doctor ... it is estimated that the disorder affects almost 50% ... complication arising from Diabetes. The high blood sugar levels ... and patients suffering from it usually tend to have ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 ... Shell Materials, Packaging, & Geography: Trends & Forecasts” ... with analysis and forecasting of the global revenue ... and restraining factors for the global food encapsulation ... The market is segmented and revenue are forecasted ...
(Date:5/25/2013)... Absolute Surgical Specialists, serving Sun City Center ... businesses throughout the country participating in Shop Local for a ... nationwide event as he understands what military families go through ... He said, “I wanted to give something back, as I ... live here too.” , Shop Local for a Cause has ...
Breaking Medicine News(10 mins):Health News:Sun Damage – Are UV Rays Addictive? 2Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2
... that would cut $6.6 million,from Medicare Advantage program ... Seniors across New,Hampshire are speaking out against proposed ... considered in the U.S. Senate. The legislation,(H.R. 6331) ... program in,New Hampshire alone and restrict seniors, health ...
... reimbursements for outpatient chemotherapy related drugs as a result ... a detrimental effect on patients requiring chemotherapy, new research ... travel distance and patient wait times for chemotherapy in ... in the July 9 issue of JAMA . ...
... to show drop-off in access predicted by critics , , ... not lost access to care despite federal legislation that ... a new report finds. , Critics feared the passing ... treatment more difficult, but investigators from the Duke Clinical ...
... recent advances in treatment, survival, study finds , , ... declines in deaths from the four most common cancers ... benefiting better educated Americans, new research from the American ... did drop significantly from 1993 to 2001, most of ...
... dietary cocktail that includes a type of omega-3 fatty ... to the latest study from MIT researchers that points ... brain diseases. , The combination of supplements, which contains ... being tested in Alzheimer,s patients. The cocktail has previously ...
... The latest developments in adipose stem cell research ... in a lab. Instead this promising revolution in ... facial fat grafting, a popular procedure developed and ... Richard Ellenbogen. Stem cell researcher and former student ...
Cached Medicine News:Health News:New Hampshire Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Medicare Modernization Act not associated with major changes in access to chemotherapy 2Health News:Medicare Modernization Act not associated with major changes in access to chemotherapy 3Health News:Cancer Care Unaffected by Doctor Reimbursement Changes 2Health News:College-Educated Fare Better When Cancer Strikes 2Health News:College-Educated Fare Better When Cancer Strikes 3Health News:Study points to cocktail therapy for Alzheimer's 2Health News:Leading Plastic Surgeons Reveal Revolution in Stem Cell Research Has its Roots in Beverly Hills Plastic Surgery 2Health News:Leading Plastic Surgeons Reveal Revolution in Stem Cell Research Has its Roots in Beverly Hills Plastic Surgery 3
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples....
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults....
... is one of the easiest tests to run ... in 15 minutes with no hands-on time. Critical ... to the child leaving the pediatrician's office and ... admission to help control the spread of RSV ...
... A & B Test simplifies rapid ... on the market just got easier ... and influenza B using one simple ... can focus on the results and ...
Medicine Products: